Company news
PAO Group, Inc. news in 2021
PAO Group, Inc.'s news releases, calls and decks from 2021, newest first.
PURA Farmersville Hemp Brand Facility Construction Update To Include USMJ, ALKM, PAOG Partnership Roles Scheduled For Tomorrow, September 9, 2021
September 8, 2021
PURA Breaks Ground On New Farmersville Hemp Brand Facility
September 3, 2021
PURA Publishes Farmersville Hemp Brand Transition Update
August 12, 2021
PURA Schedules Update To Include Latest Ongoing Partnerships With ALKM, USMJ and PAOG
August 6, 2021
PAOG Targets $18 Billion Market Opportunity With New CBD Nutraceutical To Be Packaged By ALKM And Marketed By USMJ
June 24, 2021
PAOG Confirms CBD Nutraceuticals Business Development Update To Include ALKM, USMJ and PURA Highlights Scheduled This Wednesday, June 23rd
June 21, 2021
PAOG CBD Nutraceuticals Rollout On Track Targeting $5 Billon Market
June 17, 2021
PAOG Introduces International Approach To Targeting $5 Billion CBD Nutraceutical Market
May 13, 2021
PAOG Partners With PURA, ALKM and USMJ To Launch CBD Nutraceutical Product Line
May 7, 2021
PAOG 2021 CBD Nutraceuticals Sales Plan Preview This Friday To Include ALKM and USMJ Partnership Highlights
May 6, 2021
Puration (PURA) and Alkame Holdings (ALKM) Announce All-New Sugar-Free EVERx CBD Sports Water Formula
April 30, 2021
PURA Issues Farmersville Hemp Brand Update Discussing PAOG, ALKM and USMJ Partnerships Including Pharmaceutical, Cryptocurrency And Equity Initiatives
April 20, 2021
PAOG Announces Negotiations To Acquire Partnership Interest In Patented Cannabis Extraction Technology
April 13, 2021
PAOG To Publish Latest CBD Pharmaceutical Developments Tomorrow, Tuesday April 13, 2021
April 12, 2021
PAOG U.S. Patent Backed CBD Pharmaceutical Development Remains On Track
April 8, 2021
PAOG Expects To Add CBD Nutraceuticals Revenue This Year
February 18, 2021
PAOG Confirms CBD Pharmaceutical And Nutraceutical Product Development Presentation Schedule
February 9, 2021
PAOG To Extend CBD Nutraceuticals Reach Into $3.8 Billion Market
February 4, 2021
PAOG Highlights Its Own Cannabis Pharma Tech As GW Pharma Valued At $7.2 B
February 3, 2021
PAOG Announces $50,000 Estimated Q4 2020 Revenue From Cannabis Cultivation Subsidiary
February 3, 2021
PAOG CBD Nutraceuticals Underdevelopment To Be Distributed Through USMJ
January 27, 2021
PAOG Takes Next Step To Produce Cannabis Nutraceuticals
January 27, 2021
PAOG Sets 2021 Cannabis Biopharmaceutical Revenue Goals
January 14, 2021
PAOG Engages Veristat For CRO Services To Advance CBD COPD Treatment
January 5, 2021